AbbVie (ABBV) Return on Equity (2013 - 2026)
AbbVie (ABBV) reported Return on Equity of 0.01% for Q1 2026, down 2.0% year-over-year from 0.01% in Q1 2025, and up 48.77% on a QoQ basis from 0.01% in Q4 2025.
AbbVie (ABBV) has 14 years of Return on Equity data on file, last reported at 0.01% in Q1 2026.
- Quarterly Return on Equity fell 2.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (down 2.0% YoY) and the FY2025 annual result came in at 0.9%, up 89.0% from the prior year.
- Return on Equity grew to 0.01% in Q1 2026 per ABBV's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Equity topped out at 0.06% in Q2 2025 and bottomed at 0.02% in Q3 2025.
- The 5-year median for Return on Equity is 0.01% (2022), against an average of 0.01%.
- Peak annual rise in Return on Equity reached 5 bps in 2025, while the deepest fall reached 3 bps in 2025.
- Tracing ABBV's Return on Equity over 5 years: stood at 0.01% in 2022, then tumbled by 43 bps to 0.0% in 2023, then surged by 126 bps to 0.01% in 2024, then slumped by 258 bps to 0.01% in 2025, then jumped by 49 bps to 0.01% in 2026.
- Per Business Quant, the three latest ABBV Return on Equity figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.02% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 0.01% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 0.00% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -0.01% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 0.01% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 0.00% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 0.00% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | 0.06% |
| Mar 31, 2025 | 0.02% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.01% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | 0.01% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.01% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | 0.01% |
| Jun 30, 2022 | 0.01% |
| Mar 31, 2022 | 0.01% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.01% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.02% |
| Mar 31, 2020 | -0.01% |
| Dec 31, 2019 | -0.01% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | -0.01% |
| Mar 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.01% |
| Sep 30, 2018 | -0.02% |
| Jun 30, 2018 | 0.72% |
| Mar 31, 2018 | 0.01% |
| Dec 31, 2017 | 0.03% |
| Sep 30, 2017 | -0.09% |
| Jun 30, 2017 | -0.11% |
| Mar 31, 2017 | 0.04% |
| Dec 31, 2016 | 0.03% |
| Sep 30, 2016 | -0.12% |
| Jun 30, 2016 | -0.11% |
| Mar 31, 2016 | 0.04% |
| Dec 31, 2015 | 0.03% |
| Sep 30, 2015 | -0.02% |
| Jun 30, 2015 | -0.01% |
| Mar 31, 2015 | 0.06% |
| Dec 31, 2014 | 0.04% |
| Sep 30, 2014 | 0.02% |
| Jun 30, 2014 | 0.01% |
| Mar 31, 2014 | 0.01% |
| Dec 31, 2013 | 0.01% |
| Sep 30, 2013 | 0.01% |
| Jun 30, 2013 | 0.02% |
| Mar 31, 2013 | 0.03% |